Further research using larger sample sizes and a prospective study design is necessary in order to assess the potentially causal roles of these changes to methylation levels at CpG sites in the PPP1R13L promoter region, relating to lung cancer. This evidence concerns the gene PPP1R13L and lung carcinoma.